Synopsis of recent research by authors named "Susan Y Luo"
Recent research by Susan Y Luo has focused on the role of key signaling pathways and gene expressions, particularly the Hippo signaling pathway, in the context of lung cancer, highlighting the implications of large tumor suppressor (LATS) kinases on chemotherapy response in non-small cell lung cancer.
Luo's work emphasizes the correlation of nicotinic acetylcholine receptor (nAChR) expression to lung function and its potential as a therapeutic target for treating smoking-related airway inflammation.
Additionally, her investigations into oncogenic mutations and driver mutations in lung cancer have enhanced the understanding of tumor biology, facilitating better classifications and treatment strategies based on genomic profiling.
